SCHEMBL14535307

SCHEMBL14535307

C=CCC(C#N)(C#N)Cn1cc(C(=O)OCC)c(C(F)(F)F)n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 5/20 0.39
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 1/20 0.35
P2RY12 Q9H244 4/20 0.35
IDO1 P14902 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 1/20 0.34
FOS P01100 1/20 0.34
JUN P05412 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14535209 0.86 ALDH1A1 (0.42) GRM2ALDH1A1KDM4EMAPTGAA
SCHEMBL4042559 0.82 KDM4E (0.45) GRM2ALDH1A1KDM4EGAAIDO1
SCHEMBL21408591 0.78 GRM2 (0.48) GRM2ALDH1A1KDM4EGAAIDO1
SCHEMBL2089325 0.78 KDM4E (0.50) GRM2ALDH1A1KDM4EMAPTGAA
SCHEMBL13804295 0.77 P2RX7 (0.33) ALDH1A1KDM4EMAPTKMT2AHPGD
SCHEMBL3985286 0.77 KDM4E (0.43) GRM2ALDH1A1KDM4EMAPTGAA
SCHEMBL3979049 0.76 KDM4E (0.49) GRM2ALDH1A1KDM4EMAPTGAA
SCHEMBL2087062 0.75 KDM4E (0.48) GRM2ALDH1A1KDM4EMAPTGAA
SCHEMBL3977048 0.75 KDM4E (0.48) GRM2ALDH1A1KDM4EGAAIDO1
SCHEMBL4221142 0.75 GRM2 (0.46) GRM2ALDH1A1KDM4EMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070117854-A1 Malononitrile compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117854-A1 Malononitrile compounds and use thereof ME1, DDT, CYP51A1 GRM2 1292/4885ALDH1A1 143/4885KDM4E 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.